Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal pat... von Gnant, M., Filipits, M., Greil, R., Stoeger, H., Rudas, M., Bago-Horvath, Z., Mlineritsch, B., Kwasny, W., Knauer, M., Singer, C., Jakesz, R., Dubsky, P., Fitzal, F., Bartsch, R., Steger, G., Balic, M., Ressler, S., Cowens, J.W., Storhoff, J., Ferree, S., Schaper, C., Liu, S., Fesl, C., Nielsen, T.O.

Volltext

Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy:... von Gnant, M., Sestak, I., Filipits, M., Dowsett, M., Balic, M., Lopez-Knowles, E., Greil, R., Dubsky, P., Stoeger, H., Rudas, M., Jakesz, R., Ferree, S., Cowens, J.W., Nielsen, T., Schaper, C., Fesl, C., Cuzick, J.

Volltext

Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes) von COWENS, J. W, CREAVEN, P. J, GRECO, W. R, BRENNER, D. E, TUNG, Y, OSTRO, M, PILKIEWICZ, F, GINSBERG, R, PETRELLI, N

Volltext

Analysis of Molecular Scores for the Prediction of Distant Recurrence According to Body Mass Index and Age at Baseline von Sestak, I., Dowsett, M., Ferree, S., Baehner, F.L., Cowens, J.W., Butler, S., Cuzick, J.

Volltext

Comparison of Five Different Scores for the Prediction of Late Recurrence for Oestrogen Receptor-Positive Breast Cancer von Sestak, I., Dowsett, M., Sgroi, D., Erlander, M., Ferree, S., Cowens, J.W., Cuzick, J.

Volltext

Predicting Risk for Late Metastasis: the PAM50 Risk of Recurrence (ROR) Score After 5 Years of Endocrine Therapy in Postmenopausal Women with Hr+ Early Breast Cancer: a Study On 1,... von Gnant, M., Filipits, M., Dubsky, P., Rudas, M., Balic, M., Greil, R., Ferree, S., Cowens, J.W., Schaper, C., Nielsen, T.

Volltext

DNA binding of iproplatin and its divalent metabolite cis-dichloro-bis-isopropylamine platinum(II) von PENDYALA, L, ARAKALI, A. V, SANSONE, P, COWENS, J. W, CREAVEN, P. J

Volltext

Inhibition of the development of suppressor cells in culture by 4-hydroperoxycyclophosphamide von COWENS, J. W, OZER, H, EHRKE, M. J, GRECO, W. R, COLVIN, M, MIHICH, E

Volltext

Studies on the human metabolism of iproplatin von PENDYALA, L, KRISHNAN, B. S, WALSH, J. R, ARAKALI, A. V, COWENS, J. W, CREAVEN, P. J

Volltext

Uptake and metabolism of iproplatin in murine L1210 cells von PENDYALA, L, WALSH, J. R, HUQ, M. M, ARAKALI, A. V, COWENS, J. W, CREAVEN, P. J

Volltext

A phase I clinical trial of a ribozyme-based angiogenesis inhibitor targeting vascular endothelial growth factor receptor-1 for patients with refractory solid tumors von Weng, David E, Masci, Paul A, Radka, Susan F, Jackson, T Elise, Weiss, Patricia A, Ganapathi, Ram, Elson, Paul J, Capra, William B, Parker, Vann P, Lockridge, Jennifer A, Cowens, J Wayne, Usman, Nassim, Borden, Ernest C

Volltext

Identification of prognostic genomic markers in patients with localized clear cell renal cell carcinoma (ccRCC) von Rini, B. I., Zhou, M., Aydin, H., Elson, P., Maddala, T., Knezevic, D., Parodi, L., Bukowski, R. M., Novotny, W. F., Cowens, J. W.

Volltext

A phase I clinical trial of recombinant human tumor necrosis factor given daily for five days von CREAVEN, P. J, BRENNER, D. E, COWENS, J. W, HUBEN, R. P, WOLF, R. M, TAKITA, H, ARBUCK, S. G, RAZACK, M. S, PROEFROCK, A. D

Volltext

Pharmacokinetics of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (CHIP) in patients with advanced cancer von Pendyala, L, Greco, W, Cowens, J W, Madajewicz, S, Creaven, P J

Volltext

Phase I trial of a new nitrosourea, CGP 6809, given every 2 weeks von CREAVEN, P. J, COWENS, J. W, HUBEN, R, PETRELLI, N, KARAKOUSIS, C, TRAYNOR, D

Volltext

Abstract P2-10-02: Clinical validation of the PAM50 risk of recurrence (ROR) score for predicting residual risk of distant-recurrence (DR) after endocrine therapy in postmenopausal... von Gnant, M, Filipits, M, Mlineritsch, B, Dubsky, P, Jakesz, R, Kwasny, W, Fitzal, F, Rudas, M, Knauer, M, Singer, C, Greil, R, Ferree, S, Storhoff, J, Cowens, JW, Schaper, C, Liu, S, Nielsen, T

Volltext

Identification of cis-dichloro-bis-isopropylamine platinum(II) as a major metabolite of iproplatin in humans von Pendyala, L, Cowens, J W, Chheda, G B, Dutta, S P, Creaven, P J

Volltext

S4-5: Comparison of PAM50 Risk of Recurrence (ROR) Score with OncotypeDx and IHC4 for Predicting Residual Risk of RFS and Distant-(D)RFS after Endocrine Therapy: A TransATAC Study von Dowsett, M, Lopez-Knowles, E, Sidhu, K, Pineda, S, Cowens, JW, Ferree, S, Storhoff, J, Schaper, C, Cuzick, J

Volltext

Phase I clinical trial of ethyl 6-deoxy-3,5-di-O-methyl 6-(3 methyl-3-nitrosoureido)-alpha-D-glucofuranoside (CGP 6809) von CREAVEN, P. J, MADAJEWICZ, S, RAZACK, M. S, SOLOMON, J, COWENS, J. W, PLAGER, J. E, PENDYALA, L, MITTELMAN, A, PETRELLI, N, KARAKOUSIS, C, HUBEN, R, TAKITA, H

Volltext

In vitro effects of 4-hydroperoxycyclophosphamide on human immunoregulatory T subset function. I. Selective effects on lymphocyte function in T-B cell collaboration von Ozer, H, Cowens, J W, Colvin, M, Nussbaum-Blumenson, A, Sheedy, D

Volltext